Paper32962018
Cathepsin B-Cleavable Cyclopeptidic Chemotherapeutic Prodrugs.
Herceg V and 4 others. Molecules, 2020. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Cathepsin B-Cleavable Cyclopeptidic Chemotherapeutic Prodrugs. Papers, record 32962018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32962018
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cathepsin B | Major topic |
| Peptides, Cyclic | Major topic |
| Prodrugs | Major topic |
| Amino Acid Sequence | |
| Antibiotics, Antineoplastic | |
| Cell Line, Tumor | |
| Cell Membrane Permeability | |
| Cell Survival | |
| Click Chemistry | |
| Doxorubicin | |
| G2 Phase Cell Cycle Checkpoints | |
| Humans | |
| Polyethylene Glycols | |
| Solubility |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16982417 | Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. | Neuron | 2006 | https://conductscience.org/library/papers/16982417 | PubMed |
| 2 | 16688341 | Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands. | Org Biomol Chem | 2006 | https://conductscience.org/library/papers/16688341 | PubMed |
| 3 | 1318169 | Doxorubicin inhibits human DNA topoisomerase I. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1318169 | PubMed |
| 4 | 26597527 | Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response. | Nat Rev Cancer | 2015 | https://conductscience.org/library/papers/26597527 | PubMed |
| 5 | 27215466 | Engineering a 3D microfluidic culture platform for tumor-treating field application. | Sci Rep | 2016 | https://conductscience.org/library/papers/27215466 | PubMed |
| 6 | 18325618 | Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequences. | J Control Release | 2008 | https://conductscience.org/library/papers/18325618 | PubMed |
| 7 | 7370266 | The interaction of daunorubicin and doxorubicin with DNA and chromatin. | Biochim Biophys Acta | 1980 | https://conductscience.org/library/papers/7370266 | PubMed |
| 8 | 1303755 | Total chemical synthesis, characterization, and immunological properties of an MHC class I model using the TASP concept for protein de novo design. | Protein Sci | 1992 | https://conductscience.org/library/papers/1303755 | PubMed |
| 9 | 8392002 | Doxorubicin-induced oxygen free radical formation in sensitive and doxorubicin-resistant variants of rat glioblastoma cell lines [corrected and republished erratum originally printed in FEBS Lett 1993 May 17;322(3):295-8]. | FEBS Lett | 1993 | https://conductscience.org/library/papers/8392002 | PubMed |
| 10 | 15026265 | Cysteine proteases as disease markers. | Clin Chim Acta | 2004 | https://conductscience.org/library/papers/15026265 | PubMed |
| 11 | 19109663 | Targeted delivery of activatable fluorescent pro-apoptotic peptide into live cells. | Org Biomol Chem | 2009 | https://conductscience.org/library/papers/19109663 | PubMed |
| 12 | 10699287 | Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. | J Control Release | 2000 | https://conductscience.org/library/papers/10699287 | PubMed |
| 13 | 16526790 | Chemoselectively addressable template: a valuable tool for the engineering of molecular conjugates. | J Org Chem | 2006 | https://conductscience.org/library/papers/16526790 | PubMed |
| 14 | 17869367 | Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells. | J Control Release | 2007 | https://conductscience.org/library/papers/17869367 | PubMed |
| 15 | 20638475 | Spectral analysis of doxorubicin accumulation and the indirect quantification of its DNA intercalation. | Eur J Pharm Biopharm | 2010 | https://conductscience.org/library/papers/20638475 | PubMed |
| 16 | 9973309 | Role of iron in anthracycline cardiotoxicity: new tunes for an old song? | FASEB J | 1999 | https://conductscience.org/library/papers/9973309 | PubMed |
| 17 | 9700924 | Deciphering the fluorescence signature of daunomycin and doxorubicin. | Biophys Chem | 1998 | https://conductscience.org/library/papers/9700924 | PubMed |
| 18 | 24748018 | Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment. | Curr Treat Options Cardiovasc Med | 2014 | https://conductscience.org/library/papers/24748018 | PubMed |
| 19 | 23278683 | Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. | J Pharm Pharmacol | 2013 | https://conductscience.org/library/papers/23278683 | PubMed |
| 20 | 20835451 | Application of click-click chemistry to the synthesis of new multivalent RGD conjugates. | Org Biomol Chem | 2010 | https://conductscience.org/library/papers/20835451 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40343561 | Cathepsin B in urological tumors: unraveling its role and therapeutic potential. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40343561 | PubMed |
| 37724108 | Development of stimuli responsive polymeric nanomedicines modulating tumor microenvironment for improved cancer therapy. | Med Rev (2021) | 2023 | https://conductscience.org/library/papers/37724108 | PubMed |
| 37576397 | The Role of Cathepsin B in Pathophysiologies of Non-tumor and Tumor tissues: A Systematic Review. | J Cancer | 2023 | https://conductscience.org/library/papers/37576397 | PubMed |
| 35631388 | Cathepsin B-Cleavable Polymeric Photosensitizer Prodrug for Selective Photodynamic Therapy: In Vitro Studies. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35631388 | PubMed |
| 34684822 | Double-PEGylated Cyclopeptidic Photosensitizer Prodrug Improves Drug Uptake from In Vitro to Hen's Egg Chorioallantoic Membrane Model. | Molecules | 2021 | https://conductscience.org/library/papers/34684822 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTSB | 1508 | PubTator's text mining | https://conductscience.org/library/genes/1508 | NCBI Gene |
| CYP1A2 | 1544 | PubTator's text mining | https://conductscience.org/library/genes/1544 | NCBI Gene |
| CYP24A1 | 1591 | PubTator's text mining | https://conductscience.org/library/genes/1591 | NCBI Gene |
| TOP2A | 7153 | PubTator's text mining | https://conductscience.org/library/genes/7153 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32962018
GET https://conductscience.org/api/papers/v1/32962018/references?page=2